Ker Yu
Impact in
- Molecular Biology top 2%
- PI3K/AKT/mTOR signaling in cancer
- Peroxisome Proliferator-Activated Receptors
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 45
- Genomics and Chromatin Dynamics 3
- Protein Kinase Regulation and GTPase Signaling 2
- Oncology 7
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Robert T. Abraham (11 shared papers)Lourdes Toral‐Barza (24 shared papers)James J. Gibbons (13 shared papers)Judy Lucas (20 shared papers)Arie Zask (20 shared papers)Boris Shor (6 shared papers)Semiramis Ayral‐Kaloustian (18 shared papers)Jeroen C. Verheijen (14 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (14 papers)Journal of Medicinal Chemistry (11 papers)Acta Pharmacologica Sinica (5 papers)Journal of Biological Chemistry (3 papers)Oncotarget (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Ker Yu
83 papers receiving 4.7k citations
Peers
Comparison fields: 5 of 95
- Molecular Biology 2.6k
- Cancer Research 301
- Aging 33
- Biochemistry 118
- Organic Chemistry 539
Countries citing papers authored by Ker Yu
This map shows the geographic impact of Ker Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ker Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ker Yu more than expected).
Fields of papers citing papers by Ker Yu
This network shows the impact of papers produced by Ker Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ker Yu. The network helps show where Ker Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ker Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 632 | |
| 2 | 2001 | 375 | |
| 3 | 2009 | 296 | |
| 4 | 2010 | 283 | |
| 5 | 2010 | 197 | |
| 6 | 2009 | 180 | |
| 7 | 2010 | 179 | |
| 8 | 2010 | 148 | |
| 9 | 2009 | 138 | |
| 10 | 2008 | 106 | |
| 11 | 2009 | 96 | |
| 12 | 2009 | 90 | |
| 13 | 2008 | 74 | |
| 14 | 2009 | 72 | |
| 15 | 2009 | 69 | |
| 16 | 2010 | 66 | |
| 17 | 2010 | 63 | |
| 18 | 2005 | 59 | |
| 19 | 2019 | 57 | |
| 20 | 2007 | 56 |
About Ker Yu
Ker Yu is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 84 papers that have together received 4.9k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (45 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers), Immune cells in cancer (4 papers), Microbial Natural Products and Biosynthesis (4 papers), Genomics and Chromatin Dynamics (3 papers), Adenosine and Purinergic Signaling (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Molecular Biology (2.6k citations), Cancer Research (301 citations), Aging (33 citations), Biochemistry (118 citations) and Organic Chemistry (539 citations). Ker Yu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Robert T. Abraham, Lourdes Toral‐Barza, James J. Gibbons, Judy Lucas, Arie Zask, Boris Shor, Semiramis Ayral‐Kaloustian, Jeroen C. Verheijen, Irwin J. Hollander and Christina Ravera. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Acta Pharmacologica Sinica, Journal of Biological Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.